K
50
-3
BIIB
38
-2
KMX
66
-2
EMC
71
3
HCA
44
4
FSLR
63
5
EW
53
-2
MHK
31
-3
EMR
64
-3
FOX
68
-2
STZ
54
2
PSA
48
-2
EXR
48
-3
MTCH
48
11
MLM
41
-2
ALL
41
6
CHD
34
2
UNH
44
2
ORCL
52
-7
AN
50
-5
K
50
-3
BIIB
38
-2
KMX
66
-2
EMC
71
3
HCA
44
4
FSLR
63
5
EW
53
-2
MHK
31
-3
EMR
64
-3
FOX
68
-2
STZ
54
2
PSA
48
-2
EXR
48
-3
MTCH
48
11
MLM
41
-2
ALL
41
6
CHD
34
2
UNH
44
2
ORCL
52
-7
AN
50
-5
Financhill
Back

Hisamitsu Pharmaceutical 10K Form

Buy
52

HTSUF
Hisamitsu Pharmaceutical

Last Price:
24.56
Seasonality Move:
3.79%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive HTSUF News And Ratings

See the #1 stock for the next 7 days that we like better than HTSUF

HTSUF Financial Statistics

Sales & Book Value

Annual Sales: $991.52M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $25.51
Price / Book: 0.96

Profitability

EPS (TTM): 1.29320
Net Income (TTM): $96.8M
Gross Margin: $552.55M
Return on Equity: 5.33%
Return on Assets: 4.26%

Hisamitsu Pharmaceutical Earnings Forecast

Key Hisamitsu Pharmaceutical Financial Ratios

  • The Gross Profit Margin over the past 20 years for HTSUF is 55.73%.
  • The Interest Expense is 0.13% of Operating Income.
  • The Net Earning history of HTSUF is 9.86% of Total Revenues.
  • Per Share Earnings over the last 20 years have been positive in 11 years.

Hisamitsu Pharmaceutical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: HTSUF
Website: hisamitsu.co.jp

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.53
Quick Ratio: 2.98

Price-to-Earnings

Trailing P/E Ratio: 19.35
Forward P/E Ratio: 0

HTSUF Technical Analysis vs Fundamental Analysis

Buy
52
Hisamitsu Pharmaceutical (HTSUF) is a Buy

Is Hisamitsu Pharmaceutical a Buy or a Sell?